Glen H. Murata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Glen H. Murata has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Richard M. Hoffman
University of Iowa Carver College of Medicine Iowa City Iowa USA
8 shared publications Christopher S. Wendel
3 shared publicationsJayendra H. Shah
3 shared publicationsWilliam C. Duckworth
3 shared publicationsM. Jane Mohler
2 shared publicationsAmnon Sonnenberg
1 shared publication
Latest Publications
- 1 January 2011
- Vol. 17 (1) , 49-55
A system-based intervention to improve colorectal cancer screening uptake.
To determine whether mailing guaiac-based fecal occult blood tests (gFOBTs) directly to patients who are due for colorectal cancer screening would achieve higher screening uptake than using visit-based screening. Comparative effectiveness analysis. We used an electronic medical record to identify 7053 New Mexico Veterans Affairs Health Care System patients aged 50 to 80 years who were due for screening in 2008. We invited 3869 randomly selected patients to participate in a randomized controlled trial comparing adherence with different fecal blood tests; 202 intervention patients were assigned to receive mailed gFOBTs. We identified the following 3 control groups who could receive only visit-based colorectal cancer screening: 3184 individuals who were not invited for the randomized controlled trial (control group 1), 2525 individuals who did not respond to invitations to participate in the randomized controlled trial (control group 2), and 255 individuals who could not be contacted (control group 3). We measured gFOBT screening within 3 months after enrollment in the intervention group, as well as gFOBT or colonoscopy screening within 6 months of identification as a control subject. We compared screening across groups using multivariate logistic regression analysis to adjust for sex, race/ethnicity, clinic site, previous gFOBT, and comorbidities. Colorectal screening occurred less often in each of the control groups (in 18.6% of control group 1, in 14.3% of control group 2, and in 18.8% of control group 3) than among patients mailed a gFOBT (48.5%). Adjusted odds ratios for screening among the control groups were all less than in the intervention group (adjusted odds ratios, 0.25, 0.19, and 0.23, respectively; all, P <.001). Using an electronic medical record to identify screening-eligible patients and mailing them gFOBT cards achieved higher colorectal screening uptake than performing visit-based screening.
- 1 January 2011
- Vol. 17 (1) , 49-55
A system-based intervention to improve colorectal cancer screening uptake.
To determine whether mailing guaiac-based fecal occult blood tests (gFOBTs) directly to patients who are due for colorectal cancer screening would achieve higher screening uptake than using visit-based screening. Comparative effectiveness analysis. We used an electronic medical record to identify 7053 New Mexico Veterans Affairs Health Care System patients aged 50 to 80 years who were due for screening in 2008. We invited 3869 randomly selected patients to participate in a randomized controlled trial comparing adherence with different fecal blood tests; 202 intervention patients were assigned to receive mailed gFOBTs. We identified the following 3 control groups who could receive only visit-based colorectal cancer screening: 3184 individuals who were not invited for the randomized controlled trial (control group 1), 2525 individuals who did not respond to invitations to participate in the randomized controlled trial (control group 2), and 255 individuals who could not be contacted (control group 3). We measured gFOBT screening within 3 months after enrollment in the intervention group, as well as gFOBT or colonoscopy screening within 6 months of identification as a control subject. We compared screening across groups using multivariate logistic regression analysis to adjust for sex, race/ethnicity, clinic site, previous gFOBT, and comorbidities. Colorectal screening occurred less often in each of the control groups (in 18.6% of control group 1, in 14.3% of control group 2, and in 18.8% of control group 3) than among patients mailed a gFOBT (48.5%). Adjusted odds ratios for screening among the control groups were all less than in the intervention group (adjusted odds ratios, 0.25, 0.19, and 0.23, respectively; all, P <.001). Using an electronic medical record to identify screening-eligible patients and mailing them gFOBT cards achieved higher colorectal screening uptake than performing visit-based screening.
- 1 December 2004
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 58 (10) , 551-559
Hypoglycemia in type 2 diabetes: a critical review
- 1 December 2004
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 58 (10) , 551-559
Hypoglycemia in type 2 diabetes: a critical review
- 1 December 2004
- Published by Elsevier in Journal of the American Dietetic Association
- Vol. 104 (12) , 1816-1826
Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: The diabetes outcomes in veterans study
- 1 December 2004
- Published by Elsevier in Journal of the American Dietetic Association
- Vol. 104 (12) , 1816-1826
Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: The diabetes outcomes in veterans study
- Open Access
- 12 July 2004
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (13) , 1445-1450
A Probabilistic Model for Predicting Hypoglycemia in Type 2 Diabetes Mellitus
Research from JAMA Internal Medicine — A Probabilistic Model for Predicting Hypoglycemia in Type 2 Diabetes Mellitus — The Diabetes Outcomes in Veterans Study (DOVES)
- 12 July 2004
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (13) , 1445-1450
Open AccessA Probabilistic Model for Predicting Hypoglycemia in Type 2 Diabetes Mellitus
Research from JAMA Internal Medicine — A Probabilistic Model for Predicting Hypoglycemia in Type 2 Diabetes Mellitus — The Diabetes Outcomes in Veterans Study (DOVES)
- 11 July 2003
- Published by Springer Nature in Diabetologia
- Vol. 46 (8) , 1170-1178
Factors affecting diabetes knowledge in Type 2 diabetic veterans
To describe the clinical, psychological and social factors affecting diabetes knowledge of veterans with established Type 2 diabetes.
- 11 July 2003
- Published by Springer Nature in Diabetologia
- Vol. 46 (8) , 1170-1178
Factors affecting diabetes knowledge in Type 2 diabetic veterans
To describe the clinical, psychological and social factors affecting diabetes knowledge of veterans with established Type 2 diabetes.
- 1 July 2003
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 17 (4) , 186-191
Risk factor management in stable, insulin-treated patients with Type 2 diabetes
- 1 July 2003
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 17 (4) , 186-191
Risk factor management in stable, insulin-treated patients with Type 2 diabetes
- 1 January 2002
- Vol. 18, 40-3
Small solute clearances and nutrition indices in obese patients on continuous peritoneal dialysis.
To investigate the relationship between obesity, small-solute clearances, and nutrition in continuous peritoneal dialysis (CPD), we compared clearances and nutrition indices between 270 obese and 502 normal-weight CPD patients. Degree of obesity was classified by the ratio of body weight (W) to desired weight (DW) at the first clearance study. The DWs were obtained from the tables of the Metropolitan Life Insurance Company, assuming a medium skeletal frame. The obese patients (group I) had W/DW > 1.2 (1.38 +/- 0.17), and the normal-weight patients (group II) had 0.9 < or = W/DW < or = 1.2 (1.05 +/- 0.08). Nutrition indices derived from urea nitrogen and creatinine excretion were normalized by both W and DW. The following variables differed between group I (first value) and group II: sex (women: 48.2% vs. 33.9%), W (87.6 +/- 14.4 kg vs. 68.2 +/- 8.7 kg), body surface area (1.95 +/- 0.22 m2 vs. 1.77 +/- 0.16 m2), body water by method of Watson (41.2 +/- 7.7 L vs. 36.3 +/- 5.5 L), body mass index (31.8 +/- 3.9 vs 24.3 +/- 2.0), protein nitrogen appearance (PNA: 62.9 +/- 17.6 kg in 24 h vs. 57.7 +/- 15.7 kg in 24 h), PNA normalized to DW (1.08 +/- 0.29 g/kg in 24 h vs. 0.96 +/- 0.26 g/kg in 24 h), creatinine excretion (CrEx: 1111 +/- 396 mg in 24 h vs. 991 +/- 348 mg in 24 h), CrEx/W (12.6 +/- 3.7 g/kg in 24 h vs. 15.4 +/- 4.5 g/kg in 24 h), CrEx/DW (17.3 +/- 5.3 g/kg in 24 h vs. 15.1 +/- 4.8 g/kg in 24 h), lean body mass (LBM: 49.3 +/- 13.8 kg vs. 43.6 +/- 11.9 kg), LBM/W (0.56 +/- 0.12 vs. 0.64 +/- 0.15), and LBM/DW (0.77 +/- 0.18 vs 0.67 +/- 0.16), all at p < or = 0.034. Marginal differences (0.10 > p > 0.05) were found in the diabetes prevalence (53.0% vs. 40.8%), height (165.9 +/- 11.7 cm vs. 167.4 +/- 9.8 cm), and serum albumin (3.64 +/- 0.55 g/dL vs. 3.53 +/- 0.62 g/dL). No differences were found in age, duration of CPD until the first clearance study, percent of subjects with anuria, Kt/V urea, creatinine clearance, blood urea nitrogen, serum creatinine, and PNA normalized to W. Obese CPD patients tend to have better nutrition indices than do normal-weight CPD patients with similar small-solute clearances. In obese subjects, normalization by W creates inappropriately low values for nutrition indices derived from urea nitrogen and creatinine excretion. Normalization of those indices by DW appears preferable.
- 1 January 2002
- Vol. 18, 40-3
Small solute clearances and nutrition indices in obese patients on continuous peritoneal dialysis.
To investigate the relationship between obesity, small-solute clearances, and nutrition in continuous peritoneal dialysis (CPD), we compared clearances and nutrition indices between 270 obese and 502 normal-weight CPD patients. Degree of obesity was classified by the ratio of body weight (W) to desired weight (DW) at the first clearance study. The DWs were obtained from the tables of the Metropolitan Life Insurance Company, assuming a medium skeletal frame. The obese patients (group I) had W/DW > 1.2 (1.38 +/- 0.17), and the normal-weight patients (group II) had 0.9 < or = W/DW < or = 1.2 (1.05 +/- 0.08). Nutrition indices derived from urea nitrogen and creatinine excretion were normalized by both W and DW. The following variables differed between group I (first value) and group II: sex (women: 48.2% vs. 33.9%), W (87.6 +/- 14.4 kg vs. 68.2 +/- 8.7 kg), body surface area (1.95 +/- 0.22 m2 vs. 1.77 +/- 0.16 m2), body water by method of Watson (41.2 +/- 7.7 L vs. 36.3 +/- 5.5 L), body mass index (31.8 +/- 3.9 vs 24.3 +/- 2.0), protein nitrogen appearance (PNA: 62.9 +/- 17.6 kg in 24 h vs. 57.7 +/- 15.7 kg in 24 h), PNA normalized to DW (1.08 +/- 0.29 g/kg in 24 h vs. 0.96 +/- 0.26 g/kg in 24 h), creatinine excretion (CrEx: 1111 +/- 396 mg in 24 h vs. 991 +/- 348 mg in 24 h), CrEx/W (12.6 +/- 3.7 g/kg in 24 h vs. 15.4 +/- 4.5 g/kg in 24 h), CrEx/DW (17.3 +/- 5.3 g/kg in 24 h vs. 15.1 +/- 4.8 g/kg in 24 h), lean body mass (LBM: 49.3 +/- 13.8 kg vs. 43.6 +/- 11.9 kg), LBM/W (0.56 +/- 0.12 vs. 0.64 +/- 0.15), and LBM/DW (0.77 +/- 0.18 vs 0.67 +/- 0.16), all at p < or = 0.034. Marginal differences (0.10 > p > 0.05) were found in the diabetes prevalence (53.0% vs. 40.8%), height (165.9 +/- 11.7 cm vs. 167.4 +/- 9.8 cm), and serum albumin (3.64 +/- 0.55 g/dL vs. 3.53 +/- 0.62 g/dL). No differences were found in age, duration of CPD until the first clearance study, percent of subjects with anuria, Kt/V urea, creatinine clearance, blood urea nitrogen, serum creatinine, and PNA normalized to W. Obese CPD patients tend to have better nutrition indices than do normal-weight CPD patients with similar small-solute clearances. In obese subjects, normalization by W creates inappropriately low values for nutrition indices derived from urea nitrogen and creatinine excretion. Normalization of those indices by DW appears preferable.
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A212-212
Is step-down from PPIs feasible? Prospective evaluation of a practice guideline for gastroesophageal reflux disease
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A212-212
Is step-down from PPIs feasible? Prospective evaluation of a practice guideline for gastroesophageal reflux disease